Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pro-ocular progesterone gel in moderate to severe dry eye syndrome
2019-000747-27Phase 2Completed
- Sponsor
- SIFI SpA
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of progesterone in dry eye syndrome (DED) (3 arms), sponsored by SIFI SpA. Primary endpoint: Mean change from baseline in fluorescein corneal staining by NEI scale at Week 12. Started Oct 2020; status: completed.
02
Drugs
progesterone
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2019-000747-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000747-27.